Research
Awards Grant
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients with Triple-Negative Locally Advanced Breast Cancer
AIDS Education and Training Centers Program
Bruton's Tyrosine Kinase and Immune Tolerance in Type 1 Diabetes
Cohort Study of Cancer-Inhibitory Dietary Factors in Men
Comparative Effectiveness Randomized Trial to Improve Stroke Care Delivery: C3FIT: Coordinated, Collaborative, Comprehensive, Family-based, Integrated, and Technology-enabled Care
Early Career Translational Research Award in Biomedical Engineering
High VS. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients
IUAB 1677: Optimizing Post-Allogeneic Hematopoietic Cell Transplant Outcomes for Lymphoma using Ibrutinib
Impact of MMA on Health-Related and Functional Outcomes
Increased Cardiovascular Risk and Early Natural Menopause in a Biracial Cohort
Instructional Training for Vanderbilt University-CIDRZ AIDS International Training and Research Program
Lipids and Inflammation
Molecularly Informed OCT of AMD via Imaging Mass Spectrometry Fusion
Multi-Level Social and Behavioral Determinants of Health and Missed HIV Healthcare Provider Visits
Multidisciplinary Approaches To HDL Structure, Assembly And Function
Multidisciplinary Approaches to HDL Structure, Assembly and Function
Obesity, Salt-Sensitivity, and Natriuretic Peptides
Predictors of Treatment Toxicity, Failure, and Relapse in HIV-related Tuberculosis
Prospective Observation of Cardiac Safety with Proteasome Inhibition (PROTECT)
Regulation of RNA Editing in the CNS
Role of the MC3-R in Obesity and Metabolic Syndrome
Surgical Treatment of Obstructive Sleep Apnea by Maxillomandibular Advancement
Timing of Inguinal Hernia Repair in Premature Infants: A Randomized Trial
Trajectory of Anti-Mullerian Hormone Decline and CVD Risk in CARDIA Women
Transforming STEM Learning in Urban Schools Using the SSMV Model
UAB 1640-Phase II Trial of Vosaroxin in Combination with Infusional Cytarabine in Patients with Untreated AML
UAB17127:A phase Ib trial of fulvestrant, palbociclib (CDK4/6 inhibitor) and erdafitinib (JNJ- 42756493, pan-FGFR tyrosine kinase inhibitor) in ER+/HER2–/FGFR-amplified metastatic breast cancer (MBC)
Vaccine and Treatment Evaluation Units - Admin Task
